by ASTCT Talks
In this episode of ASTCT Talks, host Christina Ferraro, nursepractitioner from the Cleveland Clinic, sits down with Vanessa Kennedy, MD, from Stanford University, to address a critical aspect of...
by Clinical Cancer Research
Data gleaned from preclinical models support glypican 2 (GPC2) as a viable target for chimeric antigen receptor (CAR) T-cell therapy in the setting of neuroblastoma and small cell lung cancer.
by Blood
Researchers have developed a neutralizing antibody with the potential to improve quality-of-life and survival outcomes in patients with immune-driven fibrotic skin conditions. EREG, a DC3...
by Transplantation and Cellular Therapy - The Official Journal of ASTCT
A single-site analysis concludes that using haploidentical donors for pediatric allogeneic hematopoietic cell transplantation (allo-HCT) is safe and effective when matched sibling donors (MSDs)...
by Transplantation and Cellular Therapy - The Official Journal of ASTCT
Researchers report that exposure to fludarabine (Flu), a component of lymphodepletion chemotherapy, may influence toxicity in patients undergoing treatment with idecabtagene-vicleucel (ide-cel).
The 2025-2026 respiratory viral season is approaching. With it comes the familiar challenge of protecting our most vulnerable patients — those who have undergone hematopoietic cell...